New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 14, 2014
09:55 EDTSHPG, PTEN, GTIV, IMMR, MFRMHigh option volume stocks: PTEN MFRM GTIV SHPG IMMR
News For PTEN;MFRM;GTIV;SHPG;IMMR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 9, 2016
17:26 EDTMFRMBerkshire Partners reports 10.4% stake in Mattress Firm
Subscribe for More Information
16:14 EDTSHPGShire initiated with a Neutral at Guggenheim
09:56 EDTSHPGIntercept higher following report of vague takeover chatter
Shares of Intercept Pharmaceuticals (ICPT) are moving after United Kingdom blog Proactive Investors discussed "reheated rumours" of a takeover. "Vague talk" has Intercept teaming up with CenterView Partners to advise on a sale, the blog states. It mentions AstraZeneca (AZN) as a possible suitor now that Shire (SHPG) has reached an agreement to acquire Baxalta (BXLT). Shares of Intercept, which is developing treatments for chronic liver diseases, are up 4% to $97.39 in early trading.
February 8, 2016
09:07 EDTMFRM40 North sends letter to board of Mattress Firm, urges board changes
40 North Management, which holds a 8.5% stake in Mattress Firm, disclosed a letter it sent to the board of directors of the company, in which the investor stated in part: "[We] are compelled to write now given our recent dialogue with the Board and the Board's decision to amend the terms of the Sleepy's acquisition on February 3rd and issue over half a million shares of Company common stock to Company insiders including J.W. Childs affiliates at a near two-year low, a transaction which can only be described as an egregious insider deal. We recognize the current volatility in the credit markets, which pushed the Board to consider various financing alternatives including further equitizing the Company. But rather than provide all shareholders the opportunity to participate in the contemplated dilutive share offering, the Board deplorably issued equity solely to its insiders when the Company's stock was trading at what a J.W. Childs representative described as a significantly undervalued price...40 North would gladly have participated in the February 3rd share issuance had it been offered the opportunity to do so, and we believe the Company would have been far better served by issuing the stock to its truly long-term shareholders rather than J.W. Childs who has been a consistent seller of the stock for years. In recent conversations with members of the Board affiliated with J.W. Childs, we discussed changes to the makeup of the current Board to address our governance concerns, including a proposal made by members of the Board to add two 40 North representatives to the Board. While we are clearly willing to serve on the Board, we ultimately concluded that the appointment of 40 North representatives alone was inadequate and a broader transformation to the composition of the Board was required to ameliorate the Company's significant corporate governance issues and shareholder misalignment. In particular, J.W. Childs must commit to taking a minority position, commensurate with its economic ownership, and to the appointment of new unaffiliated independent directors to serve as the majority."
February 5, 2016
16:08 EDTMFRMMattress Firm sees annual synergies of $40M by FY18 from Sleepy's acquisition
Mattress Firm announced the completion of its acquisition of all of the outstanding equity interests in HMK Mattress Holdings, the holding company of Sleepy's and related entities, for an aggregate purchase price of $780M, subject to working capital and other customary adjustments. The Company expects to generate annual synergies of approximately $40M by Fiscal 2018. In addition, the Company expects to receive future cash income tax benefits totaling over $11M annually for more than 10 years from the deductible tax basis goodwill generated from the transaction and from the carryover tax basis of other assets, both subject to the Company's ability to generate future taxable income. Mattress Firm expects mid-single digit EPS dilution in FY16, becoming EPS accretive in FY17 and growing to high-single digit EPS accretion by FY18, excluding one-time costs. The combined company anticipates it can generate significant free cash flow, which can be used primarily to pay down debt and/or undertake future organic growth or potential acquisitions.
10:00 EDTPTENPatterson-UTI at Raymond James
Raymond James analyst Marshall Adkins raised Patterson-UTI's price target to $21 from $17 on shares following the strong Q4 report. The analyst expects robust pressure pumping margin guidance and high-end rigs should help to support profitability in a difficult 2016 oilfield demand environment. Given Patterson's strong financial health, contract backlog and top-tier competitive positioning, Adkins believes they will be one of the core oilfield names to own heading into an anticipated 2017 recovery and reiterates his Strong Buy rating.
February 4, 2016
16:00 EDTSHPGShire's NDA for lifitegrast for dry eye resubmssion acknowledged by FDA
Shire announced that the FDA has acknowledged receipt of the resubmission of the New Drug Application for lifitegrast for the treatment of signs and symptoms of dry eye disease in adults. Shire resubmitted the NDA in response to the complete response letter received from the FDA on October 16, 2015 that requested an additional clinical study and more information related to product quality. The FDA determined that the submission is a complete response and has assigned a 6-month review period for the NDA and a Prescription Drug User Fee Act goal date of July 22.
06:07 EDTPTENPatterson-UTI reports Q4 EPS (40c), consensus (48c)
Reports Q4 revenue $339M, consensus $324.82M.
February 3, 2016
14:00 EDTMFRMMattress Firm agrees to issue 1.76M shares of common stock
On February 3, 2016, the company agreed to issue an aggregate of 1,762,236 shares of common stock. The Company expects to complete the issuance of the shares of common stock, which issuance will be equivalent to approximately 4.9% of the currently issued and outstanding shares of common stock, on February 5. The Company will receive cash in exchange for 699,300 shares and the remaining 1,062,936 shares will be issued as partial purchase price consideration in exchange for equity interests in Sleepy's. The Board of Directors of the Company approved the issuance after the close of trading on February 2 at a price per share of $35.75.
13:53 EDTMFRMMattress Firm sees Sleepy transaction mid-single digit dilutive in FY16
Subscribe for More Information
08:07 EDTSHPGMedgenics names Brian Piper to succeed John Leaman as CFO
Subscribe for More Information
06:05 EDTPTENPatterson-UTI reports drilling activity for January
Subscribe for More Information
February 2, 2016
09:46 EDTSHPGIntercept rumored to draw interest from many suitors, Daily Mail says
Subscribe for More Information
07:18 EDTPTENJefferies sees relative value in Nabors Industries
Jefferies analyst Brad Handler believes shares of Nabors Industries (NBR) can outperform Patterson-UTI (PTEN) over the near term and Helmerich & Payne (HP) over the longer term. His analysis suggests Nabors likely avoids covenant breach and has adequate liquidity to weather the downturn. Handler keeps a Hold rating on Nabors, however, with a reduced price target of $7.
January 28, 2016
10:05 EDTSHPGHigh option volume stocks
Subscribe for More Information
January 26, 2016
08:33 EDTIMMRImmersion, Tencent announce agreement on adoption of haptics in mobile game
Immersion (IMMR) and Tencent (TCEHY) announced an agreement to adopt haptics in Tencent's upcoming 3D action role playing game, "Kowloon War." Immersion will work with Timi Studios, Tencent's in-house creative studio, to design and develop tactile effects for the game.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use